LC-MS/MS Bioanalysis & PK/TK Sample Analysis
Specify drug/metabolite measurement in biological matrices for pharmacokinetic or toxicokinetic studies. An instrument platform alone is not a validated bioanalytical assay.
Methods, applicability and limitations
High-level scope references only, not standards text or a claim about a current edition. Confirm product applicability, adopted edition, jurisdiction and provider authorization before ordering.
- ICH M10 informs relevant drug-quantification assays and study-sample analysis; exploratory biomarkers need intended-use-specific justification.
- Matrix effects, selectivity, carryover, calibration, dilution and stability determine whether the assay covers your concentration range.
- Study sample acceptance, run controls, repeat analysis and incurred sample reanalysis need protocol-specific rules.
Sample and project requirements
No universal sample quantity is promised. Ask the receiving provider to confirm containers, minimum amount, preparation, hazards, storage, transport and acceptance before collection or shipment.
- Analyte/metabolites, species, matrix, anticoagulant and expected range
- Study type, sample count, collection/storage history and shipping temperature
- Sensitivity, assay status, regulated context and required data package
Compare provider proposals
- Request the selected method, suitability work, controls, detection/reporting limits and stated exclusions.
- Confirm relevant experience, actual accredited or authorized scope where needed, subcontracting and quality responsibilities.
- Agree raw data, reviewed results, interpretation, confidentiality, price and a provider-confirmed schedule.
- Laboratory Vortex coordinates requests; independent providers perform the work. No capability, award, compliance or turnaround guarantee is implied.